Ligand Pharmaceuticals LGND Income — Total revenues and other income

Similar metrics at other companies

DOUGCommissions and other brokerage income — Total revenues

$211.88M-12.1%

ALTIOther fees/income — Total Revenue

$31K+417%

RPRXOther royalty income and revenues — Total income and other revenues

$36.11M+27.9%

QTRXService and other revenue — Total revenues

$10.38M+17.6%

STTTotal other income — Topic 606 revenue

$1M—

ASSTOther revenue — Total revenues

$43K+514%

FAQ

What is Ligand Pharmaceuticals's income — total revenues and other income?

Ligand Pharmaceuticals (LGND) reported income — total revenues and other income of $5M in Q2 2026.

How has Ligand Pharmaceuticals's income — total revenues and other income changed year-over-year?

Ligand Pharmaceuticals's income — total revenues and other income increased by 391.6% year-over-year, from $1.02M to $5M.

What does income — total revenues and other income mean?

This metric represents the total revenue and income generated from ancillary business activities that fall outside of the company's core royalty and milestone-based pharmaceutical licensing operations. It captures miscellaneous contract-related earnings or non-core operational inflows that contribute to the company's top-line performance. Monitoring this figure helps investors assess the diversification of revenue streams beyond the primary drug development and partnership business model.